Business Description
Pulse Biosciences Inc
NAICS : 339113
SIC : 3841
ISIN : US74587B1017
Description
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.85 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.21 | |||||
| Debt-to-EBITDA | -0.22 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 25.1 | |||||
| 3-Year EPS without NRI Growth Rate | 25.6 | |||||
| 3-Year FCF Growth Rate | 23.5 | |||||
| 3-Year Book Growth Rate | -3.5 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.37 | |||||
| 9-Day RSI | 56.79 | |||||
| 14-Day RSI | 51.32 | |||||
| 6-1 Month Momentum % | 56.25 | |||||
| 12-1 Month Momentum % | -9.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.76 | |||||
| Quick Ratio | 6.76 | |||||
| Cash Ratio | 6.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.2 | |||||
| Shareholder Yield % | 3.97 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -146.47 | |||||
| ROA % | -60.65 | |||||
| ROIC % | -239.1 | |||||
| ROC (Joel Greenblatt) % | -462.77 | |||||
| ROCE % | -68.68 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 9.73 | |||||
| Price-to-Tangible-Book | 10.43 | |||||
| EV-to-EBIT | -8.98 | |||||
| EV-to-EBITDA | -9.23 | |||||
| EV-to-Forward-Revenue | 7.94 | |||||
| EV-to-FCF | -11.96 | |||||
| Price-to-Net-Current-Asset-Value | 13.85 | |||||
| Price-to-Net-Cash | 14.12 | |||||
| Earnings Yield (Greenblatt) % | -11.14 | |||||
| FCF Yield % | -7.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pulse Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.826 | ||
| Beta | 2.7 | ||
| Volatility % | 135.54 | ||
| 14-Day RSI | 51.32 | ||
| 14-Day ATR (€) | 0.270395 | ||
| 20-Day SMA (€) | 6.78 | ||
| 12-1 Month Momentum % | -9.68 | ||
| 52-Week Range (€) | 3.54 - 11.4 | ||
| Shares Outstanding (Mil) | 55.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pulse Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pulse Biosciences Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pulse Biosciences Inc Frequently Asked Questions
What is Pulse Biosciences Inc(FRA:6L8)'s stock price today?
The current price of FRA:6L8 is €7.20. The 52 week high of FRA:6L8 is €11.40 and 52 week low is €3.54.
When is next earnings date of Pulse Biosciences Inc(FRA:6L8)?
The next earnings date of Pulse Biosciences Inc(FRA:6L8) is 2024-05-07.
Does Pulse Biosciences Inc(FRA:6L8) pay dividends? If so, how much?
Pulse Biosciences Inc(FRA:6L8) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers